Next Article in Journal
The Effect of Antiretroviral Combination Treatment on Epstein-Barr Virus (EBV) Genome Load in HIV-Infected Patients
Next Article in Special Issue
Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections
Previous Article in Journal
Alphavirus Entry and Membrane Fusion
Previous Article in Special Issue
Recent Advances in Hepatitis C Virus Cell Entry
Article Menu

Export Article

Open AccessReview
Viruses 2010, 2(4), 826-866; doi:10.3390/v2040826

Antiviral Therapy for Hepatitis C Virus: Beyond the Standard of Care

Rega Institute for Medical Research, KULeuven, Minderbroedersstraat 10, 3000 Leuven, Belgium
These authors contributed equally to this work.
*
Author to whom correspondence should be addressed.
Received: 15 December 2009 / Revised: 9 March 2010 / Accepted: 17 March 2010 / Published: 29 March 2010
(This article belongs to the Special Issue Hepatitis Viruses)
View Full-Text   |   Download PDF [575 KB, uploaded 12 May 2015]   |  

Abstract

Hepatitis C virus (HCV) represents a major health burden, with an estimated 180 million chronically infected individuals worldwide. These patients are at increased risk of developing liver cirrhosis and hepatocellular carcinoma. Infection with HCV is the leading cause of liver transplantation in the Western world. Currently, the standard of care (SoC) consists of pegylated interferon alpha (pegIFN-α) and ribavirin (RBV). However this therapy has a limited efficacy and is associated with serious side effects. Therefore more tolerable, highly potent inhibitors of HCV replication are urgently needed. Both Specifically Targeted Antiviral Therapy for HCV (STAT-C) and inhibitors that are believed to interfere with the host-viral interaction are discussed.
Keywords: HCV; new antivirals; review HCV; new antivirals; review
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Delang, L.; Coelmont, L.; Neyts, J. Antiviral Therapy for Hepatitis C Virus: Beyond the Standard of Care. Viruses 2010, 2, 826-866.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top